price month
meet manag reinforc
convict watchman afib strategi
watchman/afib strategi set stage continu strong growth
meet bsx rhythm manag team confirm bullish view
watchman key growth driver compani next year
beyond afib ablat bsx portfolio expans deliv result
see potenti acceler driven key new product
reiter outperform rate target greater
convict meet take-away year af symposium
 market develop track approach center
left atrial appendag closur devic
lead market develop via train awar among patient
refer clinician despit signific growth watchman sale
manag continu view market
earli stage penetr remind increment
point penetr market repres mil sale
watchman flx deliv featur improv clinic
trial potenti expand market manag remain
confid new featur capabl next gener
watchman flx system close gap competit laac system
potenti thrust watchman back lead competit addit
asap post-abl patient option head-to-head vs
noac trial could expand market long-term
what new host meet boston scientif af
symposium boston includ fitzgerald evp presid rhythm
polici susi lisa vice-president investor relat
 close
valuat metric
number share
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
boston scientif corp global manufactur provid
medic devic equip area vascular intervent
structur heart men women health
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
one-year valuat scenario base
ev/ebitda ebitda bil
scenario base emerg segment deliv
growth high-growth segment grow growth
grow
one-year valuat grey scenario base
ev/ebitda grey ebitda bil
grey scenario base emerg segment deliv
growth high-growth segment grow growth
grow
 close
pipelin expans afib map ablat nearli complet lumipoint
enhanc map platform build portfolio
ablat cathet past year cathet requir
match market leader biosens webster abt/stj final
cathet compani contact forc sens cathet expect
begin studi year key pipelin product includ apama
rf balloon cryo cryterion securu thermal esophag
temperatur monitor technolog launch year addit compani
lumipoint softwar modul rhythmia hdx map system add differenti
function enhanc system enabl clinician obtain point-by-point
intellig high-dens map facilit decision-mak regard ablat
strategi arrhythmia
reimburs rate
reimburs remain aspect laac clinician provid
would like improv manag cite stabl improv
trend convers clinician reimburs profit
laac procedur remain sensit area noth new
appear inhibit adopt growth manag perspect
improv
past coupl year watchman procedur
profit center afib ablat procedur may margin
profit paid drg typic take longer therefor
compar profit per hour metric expect watchman
profit enough near term continu rapid growth trajectori
see improv profit time given eas use benefit expect
watchman flx would surpris see improv procedur
time therebi improv profit per hour time
laac watchman
charl martineau pm univers toronto compani mention price
